Molbio Diagnostics' initial public offering received 70.26 times subscription on the final day of bidding on Wednesday last ...

Molbio Diagnostics stock jumped 29% on its market debut. The point-of-care diagnostics firm''s Rs 940-crore IPO saw strong ...

According to MarketsandMarkets™, the Cancer Diagnostics Market is projected to reach USD 44.92 billion by 2031 from USD 29.86 billion in 2026, at a CAGR of 7.0% during the forecast period.

Molbio Diagnostics shares surge over 21% in debut, achieving a market valuation of ₹10,875.77 crore on the BSE.

Takeda's dengue vaccine may show up on certain dengue fever panels. But knowing when this is normal and when it is related to ...

Molbio Diagnostics shares surged over 21% on their market debut, listing at Rs 980. The IPO was subscribed 70.26 times. Learn ...

Molbio Diagnostics Ltd's shares jumped by over 21% in their market debut, starting at Rs 980 after an IPO that was 70.26 ...

Molbio Diagnostics listing gains, Molbio Diagnostics share price: Molbio Diagnostics share opened at Rs 980 on the BSE, with ...

The global body fluid analysis market is projected to grow from USD 2.62 billion in 2026 to USD 3.65 billion by 2031 at a 6.9% CAGR. Growth is driven by rising neurological, musculoskeletal, ...